Here's a tidbit that I hope Keith Olberman notes on Countdown tonight:
Coventry Health Care, parent company of HealthAmerica, which is denying Kyler Van Nocker's $110,000 claim for life-saving neuroblastoma treatment, is in extra super-duper financial shape these days.
The Dow Jones Newswires reports today that Coventry's fourth-quarter earnings rose 24%, beating profit expectations, as overall membership rose while medical costs fell.
"Coventry's medical-loss ratio, or the percentage of premium revenue used to pay patient bills, declined [to] 83.2% from 83.8% a year earlier and 84.4% in the prior quarter," notes Dow.
This has helped boost Coventry's profits to $109.1 million, or 74 cents a share, up from $88.2 million, or 60 cents, a year earlier. Revenue increased 15% to $3.43 billion as premium revenue rose 17%.
So glad the VanNocker family could help with that.